Plus Brasept
NDC Package 83318-265-41
Package Information
Plus Brasept is a . Marketed by Newdrop North America Llc, this product is identified by NDC 83318-265 and is authorized under FDA application M004.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83318 - Newdrop North America Llc
- 83318-265 - Plus Brasept
- 83318-265-41 - 3785 mL in 1 BOTTLE, PLASTIC
- 83318-265 - Plus Brasept
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83318-265-41 identifies a specific commercial package of 3785 ml in 1 bottle, plastic of Plus Brasept, labeled by Newdrop North America Llc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Newdrop North America Llc on March 23, 2023. The current certification is valid through January 31, 2025.
How is this Newdrop North America Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83318026541. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.